Glucocorticoid-mediated regulation of utrophin levels in human muscle fibers.

Abstract	Previous studies on transgenic mice indicate that upregulation of utrophin protein may offer a potential treatment strategy for Duchenne muscular dystrophy. We have analyzed the effect of the glucocorticoid 6alpha-methylprednisolone-21 sodium succinate on utrophin protein levels, using a cell-based assay with differentiated human myotubes, derived from biopsies of healthy individuals or Duchenne muscular dystrophy patients. We found that within 5-7 days 6alpha-methylprednisolone-21 sodium succinate increases utrophin protein up to approximately 40% in both normal and dystrophin-deficient myotubes compared to untreated control cultures. When analyzed in promoter-reporter assays 6alpha-methylprednisolone-21 sodium succinate activated a utrophin promoter A-fragment but did not activate a utrophin promoter B-fragment. Surprisingly, endogenous levels of utrophin mRNA in 6alpha-methylprednisolone-21 sodium succinate-treated muscle cells were unaltered indicating that the utrophin-inducing effect of glucocorticoids may be a result of post-transcriptional mechanisms. We have also analyzed 66 glucocorticoids for their effect on utrophin protein levels and found that glucocorticoids in general are able to induce utrophin protein in human myotubes.
Authors	Isabelle Courdier-Fruh, Lee Barman, Alexandre Briguet, Thomas Meier
Journal	Neuromuscular disorders : NMD (Neuromuscul Disord) Vol. 12 Suppl 1 Pg. S95-104 (Oct 2002) ISSN: 0960-8966 [Print] England
PMID	12206803 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References	Cytoskeletal Proteins Glucocorticoids Hormone Antagonists Membrane Proteins RNA, Messenger Utrophin Mifepristone Methylprednisolone
Topics	Cytoskeletal Proteins (drug effects, genetics, metabolism) Glucocorticoids (antagonists & inhibitors, metabolism, pharmacology) Hormone Antagonists (pharmacology) Humans Membrane Proteins (drug effects, genetics, metabolism) Methylprednisolone (pharmacology) Mifepristone (pharmacology) Muscle Fibers, Skeletal (metabolism) Muscular Dystrophy, Duchenne (drug therapy, metabolism) Polymerase Chain Reaction Promoter Regions, Genetic RNA, Messenger (metabolism) Up-Regulation Utrophin

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!